You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Before using Incruse Ellipta

These pages are specifically for patients who have been prescribed Incruse Ellipta. If you are not a patient please return to the public website.

Warnings and precautions 1

  • Do not use Incruse if you are allergic to umeclidinium or any of the other ingredients of this medicine (listed in the Patient Information Leaflet). If you think the above applies to you, don’t use this medicine until you have checked with your doctor.
  • Talk to your doctor before using this medicine:
    • if you have asthma (Don’t use Incruse to treat asthma) 
    • if you have heart problems 
    • if you have an eye problem called narrow-angle glaucoma 
    • if you have an enlarged prostate, difficulty passing urine or a blockage in your bladder 
    • if you have severe liver problems 
    • Check with your doctor if you think any of these may apply to you
  • If you suffer immediate breathing difficulties (tightness of the chest, coughing, wheezing or breathlessness) immediately after using your Incruse inhaler
    • Stop using this medicine and seek medical help immediately, as you may have a serious condition called paradoxical bronchospasm
  • If you get eye pain or discomfort, temporary blurring of vision, visual halos or coloured images in association with red eyes during treatment with Incruse:
    • Stop using this medicine and seek medical help immediately, these may be signs of an acute attack of narrow-angle glaucoma.

Children and adolescents

This medicine should not be given to children or adolescents below the age of 18 years.

Other medicines and Incruse Ellipta

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking other long-acting medicines similar to this medicine for breathing problems, e.g. tiotropium. You should not use Incruse as well as these other medicines.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine. You should not use this medicine if you are pregnant unless your doctor tells you so.
It is not known whether the ingredients of Incruse can pass into breast milk. If you are breast-feeding, you must check with your doctor before you use Incruse.

Driving and using machines

It is unlikely that this medicine will affect your ability to drive or use machines.

Incruse Ellipta contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before using this medicine


  1. Incruse Ellipta 55mcg Patient Information Leaflet (PIL)

INCRUSE Ellipta was developed in collaboration with INNOVIVA Inc.


These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Website: By reporting side effects you can help provide more information on the safety of this medicine.

Incruse Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies